1. Home
  2. ABCL vs WLFC Comparison

ABCL vs WLFC Comparison

Compare ABCL & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • WLFC
  • Stock Information
  • Founded
  • ABCL 2012
  • WLFC 1985
  • Country
  • ABCL Canada
  • WLFC United States
  • Employees
  • ABCL N/A
  • WLFC N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • WLFC Industrial Specialties
  • Sector
  • ABCL Health Care
  • WLFC Consumer Discretionary
  • Exchange
  • ABCL Nasdaq
  • WLFC Nasdaq
  • Market Cap
  • ABCL 1.1B
  • WLFC 1.0B
  • IPO Year
  • ABCL 2020
  • WLFC 1996
  • Fundamental
  • Price
  • ABCL $5.62
  • WLFC $131.61
  • Analyst Decision
  • ABCL Strong Buy
  • WLFC
  • Analyst Count
  • ABCL 5
  • WLFC 0
  • Target Price
  • ABCL $8.00
  • WLFC N/A
  • AVG Volume (30 Days)
  • ABCL 5.6M
  • WLFC 47.6K
  • Earning Date
  • ABCL 11-06-2025
  • WLFC 11-04-2025
  • Dividend Yield
  • ABCL N/A
  • WLFC 0.76%
  • EPS Growth
  • ABCL N/A
  • WLFC 30.03
  • EPS
  • ABCL N/A
  • WLFC 16.84
  • Revenue
  • ABCL $32,875,999.00
  • WLFC $637,163,000.00
  • Revenue This Year
  • ABCL $16.99
  • WLFC $16.17
  • Revenue Next Year
  • ABCL $62.91
  • WLFC $4.88
  • P/E Ratio
  • ABCL N/A
  • WLFC $7.82
  • Revenue Growth
  • ABCL N/A
  • WLFC 32.40
  • 52 Week Low
  • ABCL $1.89
  • WLFC $124.90
  • 52 Week High
  • ABCL $6.52
  • WLFC $235.43
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 52.96
  • WLFC 43.47
  • Support Level
  • ABCL $5.33
  • WLFC $129.39
  • Resistance Level
  • ABCL $5.97
  • WLFC $133.50
  • Average True Range (ATR)
  • ABCL 0.35
  • WLFC 3.70
  • MACD
  • ABCL -0.06
  • WLFC 0.43
  • Stochastic Oscillator
  • ABCL 32.28
  • WLFC 51.98

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

Share on Social Networks: